Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Avantor Inc. (AVTR:NYSE), powered by AI.
Avantor Inc. is currently trading at $9.39. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Avantor Inc. on Alpha Lenz.
Avantor Inc.'s P/E ratio is -12.1.
“Avantor Inc. trades at a P/E of -12.1 (undervalued) with modest ROE of -9.2%.”
Ask for details →Avantor Inc. is a prominent provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries. The company focuses on enabling science to improve the quality of life in healthcare, education, and public sectors. Avantor offers an extensive portfolio that includes laboratory chemicals, consumables, equipment, and instrumentation, which supports a wide range of scientific applications from research and development to quality control and manufacturing processes. With operations that span more than 30 countries, Avantor serves a diverse client base, including pharmaceutical and biotechnology companies, academic and government institutions, and electronic materials manufacturers. Its integrated offerings play a pivotal role in advancing research and innovation across vital sectors, reinforcing its significance in the global market. Avantor's commitment to sustainability and compliance further enhances its reputation as a responsible leader in the supply of essential science and technology products.
“Avantor Inc. trades at a P/E of -12.1 (undervalued) with modest ROE of -9.2%.”
Ask for details →Avantor Inc. (ticker: AVTR) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 13,500 employees. Market cap is $6.4B.
The current price is $9.39 with a P/E ratio of -12.05x and P/B of 1.15x.
ROE is -9.20% and operating margin is 8.30%. Annual revenue is $6.6B.